Patient-Derived Xenograft - PDX Models

Over 2,500 clinically relevant PDX models that truly mimic human disease.


Leverage the World’s Largest Collection of Highly-Characterized PDX Models

Patient-derived xenografts - PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population.

PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.

CrownBio's HuPrime® PDX collection, with over 2,500 well-characterized PDX models, supports translational preclinical oncology research into over thirty human cancer types – including rare indications and highly-specific molecular targets.


The CrownBio PDX Model Collection: 

The HuKemia® Blood Cancer PDX Collection: 

Mouse Clinical Trials with HuTrial™ 

Access the HuBase Model Database 

Discuss Your Patient-Derived Xenograft (PDX) Project